Studies of low-grade gliomas (LGGs) using neurofibromatosis type 1 (NF1) as a genetic model system describe MDK as an upstream mediator regulating the activation of T cells, the release of cytokines, and thereby tumor growth in NF1-mutant murine and human neurons (85). Here, MDK is linked to central nervous system cancer.